Age based screening for the hepatitis C virus could lead to fewer cases of advanced liver disease

Researchers from OptumInsight’s life sciences group conducted a study in conjunction with scientists from a number of leading academic and medical centers to evaluate the medical benefits and cost-effectiveness of screening the “baby boomer plus” generation born from 1946 to 1970 for the hepatitis C virus (HCV).